Endobarrier treatment for longstanding type 2 diabetes and obesity: Outcomes one-year after endobarrier in 90 consecutively treated patients

被引：0
|
作者：
Ryder, R. E. J. [1 ]
Sen Gupta, P. [2 ,3 ]
Burbridge, W. [1 ]
Irwin, S. P. [1 ]
Bashir, T. [4 ]
Allden, R. A. [5 ]
Bleasdale, J. P. [6 ]
Fogden, E. N. [5 ]
Anderson, M. R. [5 ]
Yadagiri, M. [1 ]
机构：
[1] City Hosp, Diabet, Birmingham, W Midlands, England
[2] Guys Hosp, Diabet, London, England
[3] St Thomas Hosp, Diabet, London, England
[4] City Hosp, Dietet, Birmingham, W Midlands, England
[5] City Hosp, Gastroenterol, Birmingham, W Midlands, England
[6] City Hosp, Anaesthet, Birmingham, W Midlands, England
来源：
DIABETIC MEDICINE | 2021年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P222
引用
收藏
页数：1
相关论文
共 50 条
  • [31] One-Year Efficacy and Safety of IDegLira in Patients with Type 2 Diabetes
    Gough, Stephen C. L.
    Buse, John B.
    Woo, Vincent C.
    Rodbard, Helena W.
    Linjawi, Sultan
    Poulsen, Pernille
    Korsholm, Lars
    Bode, Bruce W.
    DIABETES, 2014, 63 : A17 - A17
  • [32] Effect of the EndoBarrier Gastrointestinal Liner on obesity and type 2 diabetes: protocol for systematic review and meta-analysis of clinical studies
    Rohde, Ulrich
    Hedback, Nora
    Gluud, Lise L.
    Vilsboll, Tina
    Knop, Filip K.
    BMJ OPEN, 2013, 3 (09):
  • [33] One-year exenatide treatment improves beta cell response in metformin treated patients with type 2 diabetes which is sustained after 5 weeks discontinuation of treatment
    Bunck, M. C.
    Mari, A.
    Corner, A.
    Eliasson, B.
    Shaginian, R. M.
    Wu, Y.
    Yan, P.
    Heine, R. J.
    Smith, U.
    Taskinen, M. -R.
    Yki-Jarvinen, H.
    Diamant, M.
    DIABETOLOGIA, 2009, 52 : S7 - S7
  • [34] The United Kingdom's first NHS Endobarrier service for advanced diabesity: 1-year outcomes for all 62 treated patients
    Ryder, Robert E. J.
    Irwin, Susan P.
    Burbridge, Wyn
    Gandhi, Hardeep
    Bashir, Tahira
    Allden, Rachael A.
    Wilson, Mordel
    Wyres, Melanie
    Cull, Melissa
    Yadagiri, Mahi
    Bleasdale, John P.
    Fogden, Edward N.
    Anderson, Mark R.
    Sen Gupta, Piya
    BRITISH JOURNAL OF DIABETES, 2019, 19 (02): : 110 - 117
  • [35] One-year functional outcomes of naturalistically treated patients with schizophrenia
    Spellmann, Ilja
    Riedel, Michael
    Schennach, Rebecca
    Seemueller, Felix
    Obermeier, Michael
    Musil, Richard
    Jaeger, Markus
    Schmauss, Max
    Laux, Gerd
    Pfeiffer, Herbert
    Naber, Dieter
    Schmidt, Lutz G.
    Gaebel, Wolfgang
    Klosterkoetter, Joachim
    Heuser, Isabella
    Maier, Wolfgang
    Lemke, Matthias R.
    Ruether, Eckart
    Klingberg, Stefan
    Gastpar, Markus
    Moeller, Hans-Juergen
    PSYCHIATRY RESEARCH, 2012, 198 (03) : 378 - 385
  • [36] Endobarrier™ Duodenal-Jejunal Bypass Treatment Results in Excess Weight Loss and Rapid Improvement of Diabetes in Obese Type 2 Diabetic Patients
    Bouvy, N. D.
    de Jonge, C.
    Greve, J.
    OBESITY SURGERY, 2011, 21 (08) : 970 - 970
  • [37] UK 1st National Health Service (NHS) EndoBarrier service for uncontrolled diabesity: 2-year outcomes for all 62 treated patients
    Ryder, R. E. J.
    Yadagiri, M.
    Irwin, S. P.
    Burbridge, W.
    Wyres, M. C.
    Allden, R.
    Bashir, T.
    Bleasdale, J. P.
    Sen Gupta, P.
    Fogden, E. N.
    Anderson, M. P.
    DIABETOLOGIA, 2020, 63 (SUPPL 1) : S349 - S349
  • [38] Duodenal-jejunal bypass liner for treatment of T2DM and obesity: 4-year outcomes in the first National Health Service (NHS) EndoBarrier service
    Ryder, Robert E. J.
    Yadagiri, Mahender
    Burbridge, Wyn
    Irwin, Susan P.
    Gandhi, Hardeep
    Bashir, Tahira
    Allden, Rachael A.
    Wyres, Melanie
    Cull, Melissa
    Bleasdale, John P.
    Fogden, Edward N.
    Anderson, Mark R.
    Sen Gupta, Piya
    BRITISH JOURNAL OF DIABETES, 2022, 22 (02): : 82 - 86
  • [39] Acute and sub-acute effects of the endobarrier on glucose homeostasis and appetite in obese uncontrolled type 2 diabetes mellitus patients
    Segal-Lieberman, G.
    Lang, A.
    Lahav, M.
    Lieberman, N.
    Paster, A.
    Konvalina, N.
    Kanety, H.
    Hemi, R.
    Cohen, O.
    DIABETOLOGIA, 2014, 57 : S403 - S403
  • [40] The Effect of 1-Year's Endoscopic Proximal Intestinal Exclusion Using Endobarrier on 10-Year Cardiovascular Risk in Type 2 Diabetes
    Ryder, Robert E. J.
    Johal, Vikramdeep S.
    Murphy, Holly M.
    Littlewood, Zoe S.
    Drummond, Russell S.
    Mcgowan, Barbara M.
    Amiel, Stephanie A.
    Sen Gupta, Piya
    DIABETES, 2016, 65 : A69 - A69
12345